These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15068864)

  • 1. Imiquimod and resiquimod in a mouse model: adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery.
    Thomsen LL; Topley P; Daly MG; Brett SJ; Tite JP
    Vaccine; 2004 Apr; 22(13-14):1799-809. PubMed ID: 15068864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model.
    Otero M; Calarota SA; Felber B; Laddy D; Pavlakis G; Boyer JD; Weiner DB
    Vaccine; 2004 Apr; 22(13-14):1782-90. PubMed ID: 15068862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.
    Tüting T; Gambotto A; Robbins PD; Storkus WJ; DeLeo AB
    Gene Ther; 1999 Apr; 6(4):629-36. PubMed ID: 10476222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA.
    Zuber AK; Bråve A; Engström G; Zuber B; Ljungberg K; Fredriksson M; Benthin R; Isaguliants MG; Sandström E; Hinkula J; Wahren B
    Vaccine; 2004 Apr; 22(13-14):1791-8. PubMed ID: 15068863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization.
    Sudowe S; Dominitzki S; Montermann E; Bros M; Grabbe S; Reske-Kunz AB
    Immunology; 2009 Sep; 128(1 Suppl):e193-205. PubMed ID: 18800984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical imiquimod is a potent adjuvant to a weakly-immunogenic protein prototype vaccine.
    Johnston D; Bystryn JC
    Vaccine; 2006 Mar; 24(11):1958-65. PubMed ID: 16310898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4-producing CD4+ and CD8+ T cells.
    Oran AE; Robinson HL
    J Immunol; 2003 Aug; 171(4):1999-2005. PubMed ID: 12902504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvants may reduce in vivo transfection levels for DNA vaccination in mice leading to reduced antigen-specific CD8+ T cell responses.
    Rose AH; Hoffmann FW; Hara JH; Urschitz J; Moisyadi S; Hoffmann PR; Bertino P
    Hum Vaccin Immunother; 2015; 11(9):2305-11. PubMed ID: 26091088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod.
    Wagner TL; Ahonen CL; Couture AM; Gibson SJ; Miller RL; Smith RM; Reiter MJ; Vasilakos JP; Tomai MA
    Cell Immunol; 1999 Jan; 191(1):10-9. PubMed ID: 9918682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells.
    Gurunathan S; Stobie L; Prussin C; Sacks DL; Glaichenhaus N; Iwasaki A; Fowell DJ; Locksley RM; Chang JT; Wu CY; Seder RA
    J Immunol; 2000 Jul; 165(2):915-24. PubMed ID: 10878366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating specific priming of immune effector functions by DNA-based vaccination strategies.
    Reimann J; Schirmbeck R
    Dev Biol (Basel); 2000; 104():15-24. PubMed ID: 11713813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic and therapeutic intervention in IgE responses by biolistic DNA vaccination primarily targeting dendritic cells.
    Sudowe S; Ludwig-Portugall I; Montermann E; Ross R; Reske-Kunz AB
    J Allergy Clin Immunol; 2006 Jan; 117(1):196-203. PubMed ID: 16387606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG motif acts as a 'danger signal' and provides a T helper type 1-biased microenvironment for DNA vaccination.
    Liu L; Zhou X; Liu H; Xiang L; Yuan Z
    Immunology; 2005 Jun; 115(2):223-30. PubMed ID: 15885128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tape stripping and adjuvants on immune response after intradermal DNA electroporation.
    Vandermeulen G; Daugimont L; Richiardi H; Vanderhaeghen ML; Lecouturier N; Ucakar B; Préat V
    Pharm Res; 2009 Jul; 26(7):1745-51. PubMed ID: 19384465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in T helper 1-related immune responses in BALB/c mice immunized with an HIV-1 gag plasmid combined with a chimeric plasmid encoding interleukin-18 and flagellin.
    Chen YL; Chen YS; Hung YC; Liu PJ; Tasi HY; Ni WF; Hseuh PT; Lin HH
    Microbiol Immunol; 2015 Aug; 59(8):483-94. PubMed ID: 26094825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod.
    Gibson SJ; Lindh JM; Riter TR; Gleason RM; Rogers LM; Fuller AE; Oesterich JL; Gorden KB; Qiu X; McKane SW; Noelle RJ; Miller RL; Kedl RM; Fitzgerald-Bocarsly P; Tomai MA; Vasilakos JP
    Cell Immunol; 2002; 218(1-2):74-86. PubMed ID: 12470615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early commitment of adoptively transferred CD4+ T cells following particle-mediated DNA vaccination: implications for the study of immunomodulation.
    Creusot RJ; Thomsen LL; van Wely CA; Topley P; Tite JP; Chain BM
    Vaccine; 2001 Feb; 19(13-14):1678-87. PubMed ID: 11166891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imiquimod and S-27609 as adjuvants of DNA vaccination in a transgenic murine model of HER2/neu-positive mammary carcinoma.
    Smorlesi A; Papalini F; Orlando F; Donnini A; Re F; Provinciali M
    Gene Ther; 2005 Sep; 12(17):1324-32. PubMed ID: 15944732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant activities of immune response modifier R-848: comparison with CpG ODN.
    Vasilakos JP; Smith RM; Gibson SJ; Lindh JM; Pederson LK; Reiter MJ; Smith MH; Tomai MA
    Cell Immunol; 2000 Aug; 204(1):64-74. PubMed ID: 11006019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic mechanisms of DNA-raised antibody responses to intramuscular and gene gun immunizations.
    Boyle CM; Robinson HL
    DNA Cell Biol; 2000 Mar; 19(3):157-65. PubMed ID: 10749168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.